Global Tumor Multigene Detection Kit Market Growth 2024-2030

Global Tumor Multigene Detection Kit Market Growth 2024-2030


Tumor NGS detection kit is an experimental consumable used in tumor detection

The global Tumor Multigene Detection Kit market size is projected to grow from US$ 857.9 million in 2023 to US$ 2513.5 million in 2030; it is expected to grow at a CAGR of 16.6% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Tumor Multigene Detection Kit Industry Forecast” looks at past sales and reviews total world Tumor Multigene Detection Kit sales in 2023, providing a comprehensive analysis by region and market sector of projected Tumor Multigene Detection Kit sales for 2024 through 2030. With Tumor Multigene Detection Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Multigene Detection Kit industry.

This Insight Report provides a comprehensive analysis of the global Tumor Multigene Detection Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Multigene Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor Multigene Detection Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Multigene Detection Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Multigene Detection Kit.

United States market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Tumor Multigene Detection Kit is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Tumor Multigene Detection Kit players cover Roche Foundation Medicine, Illumina Inc., Life Technologies Corporation, Thermo Fisher Scientific and Memorial Sloan Kettering, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Multigene Detection Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Reversible End Termination Sequencing
Semiconductor Sequencing
Combined Probe Anchored Polymerization Sequencing

Segmentation by application
Companion Diagnostics
Early Cancer Screening
Drug Discovery
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Foundation Medicine
Illumina Inc.
Life Technologies Corporation
Thermo Fisher Scientific
Memorial Sloan Kettering
Novogene
Geneseeq
AmoyDx
Burning Rock Medicine
NantHealth
Personal Genome Diagnostics
GTH.O

Key Questions Addressed in this Report

What is the 10-year outlook for the global Tumor Multigene Detection Kit market?

What factors are driving Tumor Multigene Detection Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Tumor Multigene Detection Kit market opportunities vary by end market size?

How does Tumor Multigene Detection Kit break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global Tumor Multigene Detection Kit by Company
4 World Historic Review for Tumor Multigene Detection Kit by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Tumor Multigene Detection Kit by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings